Skip to main content
. 2011 Aug 31;6(8):e24167. doi: 10.1371/journal.pone.0024167

Figure 1. Kaplan Meier estimates comparing intent-to-treat Group 1 to unvaccinated control Group 3 for (A) time-to-progression (TTP) (pā€Š=ā€Š0.16) and (B) lymphoma-specific survival (LSS) (pā€Š=ā€Š0.37).

Figure 1